Tumor Cells, Cultured
"Tumor Cells, Cultured" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.
Descriptor ID |
D014407
|
MeSH Number(s) |
A11.251.860
|
Concept/Terms |
Tumor Cells, Cultured- Tumor Cells, Cultured
- Neoplastic Cells, Cultured
- Cultured Neoplastic Cells
- Cell, Cultured Neoplastic
- Cells, Cultured Neoplastic
- Cultured Neoplastic Cell
- Neoplastic Cell, Cultured
- Cultured Tumor Cells
- Cell, Cultured Tumor
- Cells, Cultured Tumor
- Cultured Tumor Cell
- Tumor Cell, Cultured
|
Below are MeSH descriptors whose meaning is more general than "Tumor Cells, Cultured".
Below are MeSH descriptors whose meaning is more specific than "Tumor Cells, Cultured".
This graph shows the total number of publications written about "Tumor Cells, Cultured" by people in this website by year, and whether "Tumor Cells, Cultured" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1987 | 0 | 3 | 3 | 1988 | 2 | 18 | 20 | 1989 | 6 | 24 | 30 | 1990 | 4 | 12 | 16 | 1991 | 3 | 26 | 29 | 1992 | 1 | 34 | 35 | 1993 | 0 | 37 | 37 | 1994 | 0 | 51 | 51 | 1995 | 1 | 46 | 47 | 1996 | 0 | 47 | 47 | 1997 | 0 | 34 | 34 | 1998 | 1 | 48 | 49 | 1999 | 2 | 40 | 42 | 2000 | 1 | 47 | 48 | 2001 | 2 | 49 | 51 | 2002 | 1 | 89 | 90 | 2003 | 1 | 41 | 42 | 2004 | 1 | 15 | 16 | 2005 | 0 | 11 | 11 | 2006 | 0 | 19 | 19 | 2007 | 0 | 13 | 13 | 2008 | 0 | 11 | 11 | 2009 | 1 | 16 | 17 | 2010 | 0 | 8 | 8 | 2011 | 0 | 12 | 12 | 2012 | 0 | 8 | 8 | 2013 | 0 | 8 | 8 | 2014 | 0 | 8 | 8 | 2015 | 0 | 14 | 14 | 2016 | 1 | 10 | 11 | 2017 | 0 | 12 | 12 | 2018 | 0 | 10 | 10 | 2019 | 0 | 8 | 8 | 2020 | 0 | 7 | 7 | 2021 | 0 | 10 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Tumor Cells, Cultured" by people in Profiles.
-
Astarita JL, Keerthivasan S, Husain B, Senbabaoglu Y, Verschueren E, Gierke S, Pham VC, Peterson SM, Chalouni C, Pierce AA, Lill JR, Gonzalez LC, Martinez-Martin N, Turley SJ. The neutrophil protein CD177 is a novel PDPN receptor that regulates human cancer-associated fibroblast physiology. PLoS One. 2021; 16(12):e0260800.
-
Bi J, Khan A, Tang J, Armando AM, Wu S, Zhang W, Gimple RC, Reed A, Jing H, Koga T, Wong IT, Gu Y, Miki S, Yang H, Prager B, Curtis EJ, Wainwright DA, Furnari FB, Rich JN, Cloughesy TF, Kornblum HI, Quehenberger O, Rzhetsky A, Cravatt BF, Mischel PS. Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug. Cell Rep. 2021 11 02; 37(5):109957.
-
Yong C, Devine SM, Abel AC, Tomlins SD, Muthiah D, Gao X, Callaghan R, Steinmetz MO, Prota AE, Capuano B, Scammells PJ. 1,3-Benzodioxole-Modified Noscapine Analogues: Synthesis, Antiproliferative Activity, and Tubulin-Bound Structure. ChemMedChem. 2021 09 16; 16(18):2882-2894.
-
Mirzapoiazova T, Xiao G, Mambetsariev B, Nasser MW, Miaou E, Singhal SS, Srivastava S, Mambetsariev I, Nelson MS, Nam A, Behal A, Arvanitis LD, Atri P, Muschen M, Tissot FLH, Miser J, Kovach JS, Sattler M, Batra SK, Kulkarni P, Salgia R. Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer. Mol Cancer Ther. 2021 10; 20(10):1820-1835.
-
Mayne CG, Toy W, Carlson KE, Bhatt T, Fanning SW, Greene GL, Katzenellenbogen BS, Chandarlapaty S, Katzenellenbogen JA, Tajkhorshid E. Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer. Mol Cancer Res. 2021 09; 19(9):1559-1570.
-
Servetto A, Kollipara R, Formisano L, Lin CC, Lee KM, Sudhan DR, Gonzalez-Ericsson PI, Chatterjee S, Guerrero-Zotano A, Mendiratta S, Akamatsu H, James N, Bianco R, Hanker AB, Kittler R, Arteaga CL. Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER+ Breast Cancer. Clin Cancer Res. 2021 08 01; 27(15):4379-4396.
-
Gkountidi AO, Garnier L, Dubrot J, Angelillo J, Harlé G, Brighouse D, Wrobel LJ, Pick R, Scheiermann C, Swartz MA, Hugues S. MHC Class II Antigen Presentation by Lymphatic Endothelial Cells in Tumors Promotes Intratumoral Regulatory T cell-Suppressive Functions. Cancer Immunol Res. 2021 07; 9(7):748-764.
-
Lu P, Wang S, Franzen CA, Venkataraman G, McClure R, Li L, Wu W, Niu N, Sukhanova M, Pei J, Baldwin DA, Nejati R, Wasik MA, Khan N, Tu Y, Gao J, Chen Y, Ma S, Larson RA, Wang YL. Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication. Blood Cancer J. 2021 02 18; 11(2):39.
-
Qi Q, Fox MS, Lim H, Bartha R, Scholl TJ, Hoffman L, Lee TY, Thiessen JD. Multimodality In Vivo Imaging of Perfusion and Glycolysis in a Rat Model of C6 Glioma. Mol Imaging Biol. 2021 08; 23(4):516-526.
-
Chen M, Brackett CM, Burdelya LG, Punnanitinont A, Patnaik SK, Matsuzaki J, Odunsi AO, Gudkov AV, Singh AK, Repasky EA, Gurova KV. Stimulation of an anti-tumor immune response with "chromatin-damaging" therapy. Cancer Immunol Immunother. 2021 Jul; 70(7):2073-2086.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|